Nayan Lamba

Also affiliated with Massachusetts General Hospital, Dana-Farber Cancer Institute, Mater Private Hospital, Dana-Farber Brigham Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma”.

Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma

JAMA Oncology(2020)10.1001/jamaoncol.2020.4937

N/A

0DataRank · unranked

29 citations

Ugonma Chukwueke, Timothy R. Smith, Keith L. Ligon, Ayal A. Aizer, David A. Reardon +2 more

Short-term outcomes associated with temozolomide vs. PCV chemotherapy for 1p/19q-codeleted WHO grade III anaplastic oligodendrogliomas: a national evaluation

medRxiv(2020)10.1101/2020.03.29.20046805

N/A

0DataRank · unranked

0 citations

Malia McAvoy, Vasileios K. Kavouridis, Timothy R. Smith, Mehdi Touat, David A. Reardon +2 more

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

Neuro-Oncology(2022)10.1093/neuonc/noac118

N/A

0DataRank · unranked

194 citations

Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos +20 more